Pfizer R&D, Comparative Medicine, Global Science & Technology, Groton, CT, USA.
Pfizer Consumer Healthcare, Madison, NJ, USA.
Osteoarthritis Cartilage. 2017 Dec;25(12):2080-2090. doi: 10.1016/j.joca.2017.08.013. Epub 2017 Sep 6.
The aim of this study was to determine the ability of undenatured native chicken type II collagen (UC-II) to prevent excessive articular cartilage deterioration in a rat model of osteoarthritis (OA).
Twenty male rats were subjected to partial medial meniscectomy tear (PMMT) surgery to induce OA. Immediately after the surgery 10 rats received vehicle and another 10 rats oral daily dose of UC-II at 0.66 mg/kg for a period of 8 weeks. In addition 10 naïve rats were used as an intact control and another 10 rats received sham surgery. Study endpoints included a weight-bearing capacity of front and hind legs, serum biomarkers of bone and cartilage metabolism, analyses of subchondral and cancellous bone at the tibial epiphysis and metaphysis, and cartilage pathology at the medial tibial plateau using histological methods.
PMMT surgery produced moderate OA at the medial tibial plateau. Specifically, the deterioration of articular cartilage negatively impacted the weight bearing capacity of the operated limb. Immediate treatment with the UC-II preserved the weight-bearing capacity of the injured leg, preserved integrity of the cancellous bone at tibial metaphysis and limited the excessive osteophyte formation and deterioration of articular cartilage.
Study results demonstrate that a clinically relevant daily dose of UC-II when applied immediately after injury can improve the mechanical function of the injured knee and prevent excessive deterioration of articular cartilage.
本研究旨在确定未变性天然鸡 II 型胶原蛋白(UC-II)在骨关节炎(OA)大鼠模型中预防关节软骨过度退变的能力。
20 只雄性大鼠接受内侧半月板部分切除术(PMMT)手术以诱导 OA。手术后立即,10 只大鼠给予载体,另 10 只大鼠给予 UC-II 每日口服剂量 0.66mg/kg ,持续 8 周。此外,10 只未处理的大鼠作为完整对照组,另 10 只大鼠接受假手术。研究终点包括前肢和后肢的承重能力、骨和软骨代谢的血清生物标志物、胫骨骺和干骺端的软骨下和松质骨分析,以及使用组织学方法分析内侧胫骨平台的软骨病理学。
PMMT 手术导致内侧胫骨平台发生中度 OA。具体来说,关节软骨的恶化对手术肢体的承重能力产生负面影响。UC-II 的即时治疗可维持受伤腿部的承重能力,维持胫骨干骺端松质骨的完整性,并限制骨赘形成和关节软骨过度退变。
研究结果表明,临床相关的每日剂量 UC-II 可改善受伤膝关节的机械功能,防止关节软骨过度退变。